发明名称 Antiviral transgenic plants, vectors, cells and methods
摘要 Isolated 2-5A-dependent RNases, an interferon-induced enzyme which is activated by 5'-phosphorylated, 2',5'-linked oligoadenylates (2-5A) and implicated in both the molecular mechanisms of interferon action and in the fundamental control of RNA stability in mammalian cells, and encoding sequences therefor are disclosed. The expression cloning and analysis of murine and human 2-5A-dependent RNases is also disclosed. Recombinant human 2-5A-dependent RNase produced in vitro bound an activating affinity matrix, 2-5A-cellulose, resulting in ribonuclease activity. The 2-5A binding properties of the recombinant and naturally occurring forms of 2-5A-dependent RNase are basically identical. Interferon induction of 2-5A-dependent RNase expression is demonstrated by measuring the mRNA levels in cells treated with interferon and cycloheximide. Analysis of aligned murine and human 2-5A-dependent RNase sequences revealed several features, including similarity to RNase E which is implicated in the control of mRNA stability in E. coli. A duplicated phosphate-binding loop motif is determined by deletion analysis and site-directed mutagenesis to function in the binding of 2-5A. In addition, recombinant nucleotide sequences, recombinant vectors, recombinant cells and antiviral plants which express, for example, amino acid sequences which have activity that interfere with or inhibit viral replication are disclosed.
申请公布号 US5866781(A) 申请公布日期 1999.02.02
申请号 US19950434998 申请日期 1995.05.08
申请人 THE CLEVELAND CLINIC FOUNDATION 发明人 SILVERMAN, ROBERT H.;SENGUPTA, DIBYENDU N.
分类号 A01H1/00;C12N9/12;C12N9/22;C12N15/82;(IPC1-7):A01H5/00;C12N15/12 主分类号 A01H1/00
代理机构 代理人
主权项
地址